Institute of Pharmacy and Pharmacology,University of South China,Institute of Pharmacy and Pharmacology,University of South China,Institute of Pharmacy and Pharmacology,University of South China
This work was supported by grants from The National Natural Science Foundation of China(81270420, 81470434), Natural Science Foundation of Hunan Province Combined (Hengyang) Fund Project(12JJ8013), Hunan Province Natural Science Foundation of China (14JJ3102) and Twelfth Five Year Key Disciplines in Hunan Construction Projects, The Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study [Hunan Provincial Education Department document(Approval number: 2014-405)]
Apelin is the endogenous ligand of apelin-angiotensin receptor-like 1(APJ). Apelin/APJ system widely distributed in the body, with high expression level in the vascular system, such as cardiovascular system, pulmonary vascular system. The study found that apelin can regulate vascular tone and inducevascular smooth muscle cell proliferation, promote retinal neovascularization, mononuclear cell adhesion to endothelial cells and hepatic portal vein and coronary collateral formation. In this review, we summarized the actions of apelin regulating blood vessel function and the related diseases (hypertension, pulmonary hypertension, atherosclerosis, glioma, lung cancer, portal hypertension and diabetic angiopathy). Moreover, we revealed the inner connection of apelin with vascular and its related diseases, and show that apelin/APJ can be used as therapeutic targets of vascular disease.
CAO Jian-Gang, LI Lan-Fang, CHEN Lin-Xi. Apelin/APJ: Vascular Function Regulatory Factor and New Targets for Drug Treatment[J]. Progress in Biochemistry and Biophysics,2015,42(8):721-732
Copy® 2025 All Rights Reserved ICP:京ICP备05023138号-1 京公网安备 11010502031771号